Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes Full Text
BMC Psychiatry,  Clinical Article

Chen CH et al. – Carbamazepine (CBZ) is efficacious in the maintenance treatment of bipolar disorder in naturalistic clinical practice, either as monotherapy or in combination with other medications. CBZ is well tolerated by most patients in this patient group.

Methods
  • Bipolar patients diagnosed according to the DSM-IV system and treated with CBZ at the Taipei City Psychiatric Centre had their charts reviewed to evaluate the efficacy and side effects of this medication during an average follow-up period of 10 years.

Results
  • A total of 129 bipolar patients (45 males, mean age: 45.7 +/- 10.9 year) were included in the analysis of CBZ efficacy used alone (n = 63) or as an add-on after lithium (n = 50) or valproic acid (n = 11), or the both of them (n = 5).
  • The mean age of disease onset was 24.6 +/- 9.5 years.
  • The mean duration of CBZ use was 10.4 +/- 5.2 year.
  • The mean dose used was 571.3 +/- 212.6 mg/day with a mean plasma level of 7.8 +/- 5.9 ug/mL.
  • Mean body weight increased from 62.0 +/- 13.4 kg to 66.7 +/- 13.1 kg during treatment.
  • The frequencies of admission per year before and after CBZ treatment were 0.33 +/- 0.46 and 0.14 +/- 0.30, respectively.
  • The most common side effects targeted the central nervous system (24%), including dizziness, ataxia and cognitive impairment. Other common side effects were gastrointestinal disturbances (3.6%), tremor (3.6%), skin rash (2.9%), and blurred vision (2.9%).
  • Eighty-eight patients (68.2%) were taking antipsychotics concomitantly.
  • Ninety-six patients (74.4%) needed to use benzodiazepines concomitantly.
  • Sixty-three (48.8%) patients had zero episodes in a 10-year follow-up period, compared to all patients having episodes prior to treatment.
  • Using variable analysis, the authors found better response to CBZ in males than in females.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Zolpidem and the risk of Parkinson's disease: A nationwide population-based study Journal of Psychiatric Research, August 1, 2014    Clinical Article

2 Antidepressants and the risk of hyponatraemia: A class-by-class review of the literature Psychosomatics, September 15, 2014    Review Article

3 Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis Schizophrenia Research, September 24, 2014    Clinical Article

4 Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis European Neuropsychopharmacology, September 2, 2014    Evidence Based Medicine    Review Article

5 Prazosin in the treatment of PTSD Journal of Psychiatric Practice, July 25, 2014    Review Article

6 Association between early temperament and depression at 18 years Depression and Anxiety, August 18, 2014    Clinical Article

7 The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial Psychiatry Research, August 5, 2014    Clinical Article

8 Adipokines as emerging depression biomarkers: A systematic review and meta-analysis Journal of Psychiatric Research, September 18, 2014    Evidence Based Medicine    Clinical Article

9 Latent inhibition in ADHD adults on and off medication: A preliminary study Journal of Attention Disorders, September 10, 2014    Clinical Article

10 Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study Journal of Affective Disorders, July 17, 2014    Clinical Article

11 Adipokines as emerging depression biomarkers: A systematic review and meta-analysis Journal of Psychiatric Research, September 3, 2014    Evidence Based Medicine    Clinical Article

12 Third-wave cognitive therapy versus mentalisation-based treatment for major depressive disorder: a randomised clinical trial BMJ Open, September 9, 2014    Clinical Article

13 The importance of cytokines and autoantibodies in depression Autoimmunity Reviews, September 25, 2014    Review Article

14 Risk of diabetes in children and adolescents exposed to antipsychotics: A nationwide 12-year case-control study Journal of the American Academy of Child & Adolescent Psychiatry, September 4, 2014    Clinical Article

15 Increased cortisol awakening response was associated with time to recurrence of major depressive disorder Psychoneuroendocrinology, August 22, 2014    Clinical Article

16 Association between autoimmune thyroiditis and depressive disorder in psychiatric outpatients European Archives of Psychiatry and Clinical Neuroscience, September 17, 2014    Clinical Article

17 Oral contraceptive use and psychiatric disorders in a nationally representative sample of women Archives of Women's Mental Health, August 29, 2014    Clinical Article

18 Vascular Endothelial Growth Factor: A potential diagnostic biomarker for major depression Journal of Psychiatric Research, September 19, 2014    Clinical Article

19 Efficacy of acupuncture in reducing preoperative anxiety: a meta-analysis Full Text Evidence-based Complementary and Alternative Medicine , September 5, 2014    Free full text    Evidence Based Medicine    Review Article

20 Metacognitions and thought control strategies in unipolar major depression: A comparison of currently depressed, previously depressed, and never-depressed individuals Cognitive Therapy and Research, September 5, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close